BioSapien is a biotech company focused on developing a 3D printed drug delivery platform to provide FDA-approved drugs directly and efficiently to tumor site - both efficient, efficacious and having a reduced negative systemic effects. Having facilities and a personnel presence in both New York, NY and in San Diego CA. BioSapien is structured around development of the Medichip(tm) - 3D printed biodegradable mesh chip designed to deliver cancer drugs directly to the tumor site while reducing side effects. The Chip functions as animplantable, biodegradable, drug-eluting mesh targeting several treatment-resistant features of pancreatic cancer by delivering high-concentration chemotherapy to unresectable structures (i.e. major vasculature) and poorly perfused, fibrotic, tumor tissues which have thus-far dramatically limited the success of surgery and chemotherapy.
